SPHERA FUNDS MANAGEMENT LTD. - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q1 2022$3,113,000
-20.9%
26,529
+12.4%
0.44%
+26.1%
Q4 2020$3,936,000
-21.8%
23,599
-27.6%
0.35%
-29.4%
Q3 2020$5,031,000
-1.0%
32,599
-5.2%
0.49%
+3.3%
Q2 2020$5,084,000
+38.6%
34,373
+5.5%
0.48%
+4.1%
Q1 2020$3,668,000
-64.3%
32,573
-55.8%
0.46%
-45.7%
Q4 2019$10,263,000
+44.4%
73,7730.0%0.85%
-23.0%
Q3 2019$7,106,000
-16.4%
73,7730.0%1.10%
-5.5%
Q2 2019$8,495,000
+5.7%
73,773
+8.1%
1.16%
+58.5%
Q1 2019$8,036,000
+120.1%
68,273
+17.2%
0.73%
+77.9%
Q4 2018$3,651,000
-44.4%
58,273
-37.1%
0.41%
-45.4%
Q3 2018$6,567,000
+26.5%
92,673
+18.7%
0.75%
+5.3%
Q2 2018$5,192,000
-16.8%
78,048
-18.3%
0.72%
-24.5%
Q1 2018$6,244,000
+20.4%
95,474
-26.3%
0.95%
+55.7%
Q4 2017$5,187,000
+10.5%
129,4740.0%0.61%
-9.1%
Q3 2017$4,693,000
+4.6%
129,474
-19.9%
0.67%
-12.1%
Q2 2017$4,486,000
-37.3%
161,617
-36.7%
0.76%
-45.5%
Q1 2017$7,153,000
+8.2%
255,455
-21.8%
1.40%
-16.4%
Q4 2016$6,611,000
+24.8%
326,622
+24.0%
1.67%
+94.1%
Q3 2016$5,296,000
+52.4%
263,500
+0.6%
0.86%
-4.4%
Q2 2016$3,474,000
+185.9%
261,800
+274.0%
0.90%
+615.9%
Q1 2015$1,215,00070,0000.13%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders